Rethinking Side Effects of the Selective Serotonin Reuptake Inhibitors: Sexual Dysfunction and Weight Gain
Authors:
- Norman SussmanNSNorman Sussman
- David GinsbergDGDavid Ginsberg
- 1 February 1998
- journal article
- Published by SLACK, Inc. in Psychiatric Annals
- Vol. 28 (2) , 89-97
Abstract
No abstract availableThis publication has 55 references indexed in Scilit:
- Fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patientsJournal of Sex & Marital Therapy, 1997
- Sertraline-Induced Anorgasmia Treated With Intermittent NefazodoneThe Journal of Clinical Psychiatry, 1997
- Intermittent amantadine for fluoxetine-induced anorgasmiaJournal of Sex & Marital Therapy, 1996
- NITRIC OXIDE SYNTHASE: Role as a Transmitter/Mediator in the Brain and Endocrine SystemAnnual Review of Medicine, 1996
- Successful treatment of citalopram‐induced anorgasmia by cyproheptadineActa Psychiatrica Scandinavica, 1996
- Drugs That Cause Weight GainObesity Research, 1995
- Sertraline and Relapse Prevention Training Following Treatment by Very‐Low‐Calorie Diet: A Controlled Clinical TrialObesity Research, 1995
- Cyproheptadine Treatment of Sexual Dysfunction Induced by Serotonin Reuptake InhibitorsClinical Neuropharmacology, 1995
- A double‐blind, comparative, multicentre study comparing paroxetine with fluoxetine in depressed patientsActa Psychiatrica Scandinavica, 1993
- Nitric Oxide: First in a New Class of NeurotransmittersScience, 1992